netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
News
News Title
news

 Last updated: 27th March 2024

Formulary Amendments
Chapter Change Reason for change
02.15 Empagliflozin for the treatment of chronic heart failure with preserved or midly reduced ejection fraction NICE TA929
05.01 Addition of link to NENC Penicillin Allergy Assessment primary care for adult patients NENC Medicines Subcommittee Approval
13.04 Removal of Betnovate N cream NENC Medicines Subcommittee Approval
01.04.02 Removal of loperamide oral liquid and amended wording for orodispersible  NENC Medicines Subcommittee Approval
01.05.01 Shared care guideline link added to sulfasalazine NENC Medicines Subcommittee Approval
01.06.07 Addition of chronic constipation in men as an approved indication for prucalopride NENC Medicines Subcommittee Approval
02.02.01 Removal of treatment to be initiaited by cardiology NENC Medicines Subcommittee Approval
02.02.03 Addition of prescribing guideline for finerenone NENC Medicines Subcommittee Approval
02.03.02 Shared care guideline link amended for amiodarone NENC Medicines Subcommittee Approval
02.03.02 Shared care guideline link amended for dronedarone NENC Medicines Subcommittee Approval
02.08.01 Removal of local guidance for low molecular weight heparins NENC Medicines Subcommittee Approval
02.08.02 Removal of Tees Valley Warfarin guidelines for primary care NENC Medicines Subcommittee Approval
02.08.02 Removal of NENC DOAC decision support table NENC Medicines Subcommittee Approval
03.04.01 Promethazine changed from alternative to second choice NENC Medicines Subcommittee Approval
04.01.01 Addition of daridorexant for the treatment of long-term insomnia NENC Medicines Subcommittee & NICE TA922
04.03.03 Addition of sertraline 100mg/5ml concentrate for oral solution  NENC Medicines Committee approval
04.07.02 Addition of fentanyl nasal spray for use by children NENC Medicines Committee Approval
04.07.02 Addition of morphie sulfate (MST) 5mg tablets NENC Medicines Committee Approval
04.07.04.02 Addition of rimegepant for treating migraine NICE TA919
04.09.01 Foslevidopa/foscarbidopa for the treatment of advanced Parkinson’s with motor symptoms in adults NICE TA934
04.09.01 Opicapone changed to 1st choice  NENC Medicines Committee Approval
04.09.01 Bromocriptine - County Durham and Tees Valley shared care guideline removed NENC Medicines Committee Approval
04.09.03 Link to riluzole shared care guideline added and formulation changed from orodispersible tablet to orodispersible film NENC Medicines Committee Approval
06.01.02.01 Removal of gliclazide MR tablets for new patients NENC Medicines Committee Approval
06.01.02.03 Semaglutide (Wegovy). Changed from Brown to Red NENC Medicines Subcommittee Approval & NICE TA875
06.01.02.03 Addition of tirzepatide for the treatment of type 2 diabetes  NENC Medicines Subcommittee Approval & NICE TA924
06.06.02 Denosumab - changed from Green plus to Amber.  NENC Medicines Committee Approval
08.01.05 Lutetium (177Lu) oxodotreotide (Lutathera) for treating unresectable or metastatic neuroendocrine tumours in adults NICE TA930
08.01.05 Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma in adults after 2 or more systemic therapies. Moved from approved to Non-Formulary NICE TA933
08.01.05 Idecabtagene vicleucel for treating relapsed and frefractory multuiple myeloma after 3 or more treatments. Added to non-formulary NICE TA936
09.05.02.02 Sevelamer and lanthanum changed from Red to Green Plus NENC Medicines Committee Approval
09.08.01 Pegunigalsidase alfa for treating Fabry disease NICE TA915 & NHSE SSC2600
10.01.01 Celecoxib changed from Green Plus to Green NENC Medicines Committee Approval
11.03.03 Ganciclovir ophthalmic gel changed to 1st choice.  NENC Medicines Committee Approval
12.03.01 Caphosol and Gelclair changed from Red to Green Plus NENC Medicines Committee Approval
13.05.03 Baricitinib for treating severe alopecia areata (Not recommended) NICE TA926
15.01.02 Removal of desflurane NENC Medicines Committee Approval
About page Addition of position statement on the prescribing of branded generic medicines NENC Medicines Committee Approval
    
27/03/2024
   

 

 

 

 


netFormulary